ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1121

$1.39M Total Retail Price of All Prescriptions

Rank: 21 out of 1121

807 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 807 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 807 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 21,437 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 1,145 826 1 4
SIMVASTATIN 1,133 898 2 1
AMLODIPINE BESYLATE 807 644 3 5
LEVOTHYROXINE SODIUM 802 712 4 2
OMEPRAZOLE 745 532 5 6
HYDROCHLOROTHIAZIDE 688 623 6 10
METOPROLOL TARTRATE 636 536 7 9
FUROSEMIDE 612 522 8 7
POTASSIUM CHLORIDE 565 506 9 12
HYDROCODONE-ACETAMINOPHEN 559 455 S3 10 3
METFORMIN HCL 550 422 11 8
CITALOPRAM HBR 455 402 12 18
CLONIDINE HCL 363 294 13 39
WARFARIN SODIUM 326 291 14 11
ZOLPIDEM TARTRATE 325 248 15 19
ATENOLOL 319 264 16 16
ATORVASTATIN CALCIUM 305 196 17 15
LANTUS 301 246 18 52
GABAPENTIN 296 243 19 13
ALENDRONATE SODIUM 291 254 20 37
TRAMADOL HCL 290 268 21 25
EXELON 288 288 22 119
ESCITALOPRAM OXALATE 273 237 23 94
DONEPEZIL HCL 270 269 24 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 267 189 25 31
TAMSULOSIN HCL 244 183 26 32
LOVASTATIN 242 223 27 26
CARVEDILOL 235 219 28 20
CLOPIDOGREL 229 202 29 27
NAMENDA 214 214 30 53
LEVOFLOXACIN 211 161 31 79
MIRTAZAPINE 188 185 32 56
GEMFIBROZIL 179 101 33 88
PRAVASTATIN SODIUM 177 149 34 14
TERAZOSIN HCL 167 145 35 130
ALLOPURINOL 165 135 36 30
PLAVIX 158 143 37 42
GLYBURIDE 153 127 R 38 51
DIOVAN HCT 152 144 39 90
RISPERIDONE 152 135 39 82
NEXIUM 150 122 41 24
SPIRIVA 149 129 42 49
POLYETHYLENE GLYCOL 3350 144 136 43 70
CRESTOR 139 112 44 28
ACTOS 137 114 45 133
METOPROLOL SUCCINATE 135 126 46 23
LYRICA 134 78 47 76
CYMBALTA 127 83 48 50
DICLOFENAC POTASSIUM 125 92 49 336
RANITIDINE HCL 124 116 50 33
EVISTA 123 112 51 143
TRAZODONE HCL 122 99 52 40
ALBUTEROL SULFATE 117 103 53 141
PROAIR HFA 117 79 53 48
SYNTHROID 116 100 55 55
PROMETHAZINE HCL 115 67 R 56 67
PREDNISONE 114 97 57 43
PANTOPRAZOLE SODIUM 113 86 58 29
JANUVIA 112 101 59 81
GLIMEPIRIDE 111 100 60 34
LOSARTAN-HYDROCHLOROTHIAZIDE 108 96 61 46
ADVAIR DISKUS 106 68 62 64
LOSARTAN POTASSIUM 104 71 63 17
LEVETIRACETAM 103 53 64 125
BENAZEPRIL HCL 98 87 65 41
SPIRONOLACTONE 96 78 66 54
CEFTRIAXONE 96 80 66 197
DIOVAN 95 90 68 45
DIGOXIN 93 91 69 59
FLUOXETINE HCL 92 52 70 60
FLUTICASONE PROPIONATE 91 50 71 36
PHENYTOIN SODIUM EXTENDED 90 71 72 135
DIVALPROEX SODIUM 90 62 72 98
SERTRALINE HCL 82 79 74 21
IBUPROFEN 81 44 75 110
FINASTERIDE 80 80 76 117
DOXYCYCLINE HYCLATE 80 71 76 103
OLANZAPINE 80 64 76 181
PROPRANOLOL HCL 79 79 79 123
ISOSORBIDE MONONITRATE ER 76 68 80 62
QUETIAPINE FUMARATE 75 69 81 75
FENTANYL 74 52 S2 82 100
JANTOVEN 72 72 83 146
METOCLOPRAMIDE HCL 72 58 83 120
RAMIPRIL 71 62 85 74
NYSTATIN 71 52 85 147
CARBIDOPA-LEVODOPA 69 59 87 118
VENTOLIN HFA 68 40 88 92
TAMIFLU 66 55 89 389
AMLODIPINE BESYLATE-BENAZEPRIL 65 50 90 65
XARELTO 65 60 90 443
KLOR-CON M20 64 55 92 85
IPRATROPIUM-ALBUTEROL 64 61 92 160
FAMOTIDINE 64 62 92 63
COMBIVENT 64 55 92 129
TRICOR 63 52 96 126
KLOR-CON 10 62 51 97 69
QUINAPRIL HCL 62 62 97 127
BETAMETHASONE VALERATE 61 38 99 393
PRAMIPEXOLE DIHYDROCHLORIDE 61 50 99 158
NOVOLIN R 61 53 99 174
ROPINIROLE HCL 60 47 102 91
VENLAFAXINE HCL ER 60 60 102 113
BUSPIRONE HCL 60 57 102 114
ZETIA 60 45 102 80
HYDRALAZINE HCL 59 41 106 66
LIPITOR 57 50 107 106
MECLIZINE HCL 55 51 108 115
METFORMIN HCL ER 55 52 108 47
DOXAZOSIN MESYLATE 54 50 110 93
HYDROXYZINE HCL 53 35 R 111 168
HUMULIN R 52 49 112 227
TORSEMIDE 51 48 113 155
NAPROXEN 51 41 113 116
HUMALOG 50 30 115 150
LEVEMIR 50 38 115 157
GLIPIZIDE 50 50 115 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.